Related Experiment Video
Updated: Feb 6, 2026

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
Published on: June 27, 2025
Imaging of Pulmonary Hypertension
Christopher J François1, Mark L Schiebler1
1Department of Radiology, University of Wisconsin - Madison, 600 Highland Avenue, E1/Clinical Science Center, Madison, WI 53792, USA.
Noninvasive imaging, especially CT and MR, aids in diagnosing pulmonary hypertension (PH) and assessing its impact on the right ventricle. These advanced techniques offer better evaluation than initial imaging studies for PH management.
Area of Science:
- Radiology
- Cardiology
- Pulmonology
Background:
- Noninvasive imaging is crucial for pulmonary hypertension (PH) diagnosis and management.
- Initial imaging like chest radiography and echocardiography have limitations in evaluating the right ventricle (RV) and pulmonary vasculature.
- Computed tomography (CT) and magnetic resonance (MR) imaging are gaining prominence for PH assessment.
Purpose of the Study:
- To describe noninvasive imaging techniques for pulmonary hypertension (PH).
- To highlight the role of CT and MR imaging in diagnosing PH and assessing RV function.
- To review imaging findings in the management of suspected or known PH.
Main Methods:
- Review of noninvasive imaging modalities for pulmonary hypertension (PH).
- Focus on computed tomography (CT) and magnetic resonance (MR) imaging.
- Description of imaging findings related to PH and RV function.
Main Results:
- Chest radiography, V/Q scintigraphy, and Doppler echocardiography are initial PH evaluation tools but have limitations.
- CT and MR imaging provide detailed assessment of pulmonary vasculature and RV function in PH.
- Specific CT and MR findings aid in identifying causes and effects of PH.
Conclusions:
- Advanced imaging like CT and MR are valuable for PH diagnosis and management.
- These techniques improve the evaluation of the right ventricle and pulmonary vasculature in PH.
- Noninvasive imaging plays a key role in the comprehensive care of PH patients.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...

